Related Experiment Video

Updated: May 14, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
06:46

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19

Published on: July 5, 2022

Telemedicine in paediatric patients with poorly controlled type 1 diabetes

Y Sammy Choi1, Cristóbal Berry-Cabán, Julie Nance

  • 1Departments of Medicine and Pediatrics, Fort Bragg, North Carolina, USA.

Journal of Telemedicine and Telecare
|February 13, 2013
PubMed

Insights

This study found that telemedicine effectively lowered hemoglobin A1c (HbA1c) levels in pediatric patients with type 1 diabetes. However, the remote approach did not achieve optimal diabetes control.

Area of Science:

  • Pediatric Endocrinology
  • Digital Health
  • Diabetes Management

Background:

  • Type 1 diabetes requires continuous management.
  • Poorly controlled diabetes in children poses long-term health risks.
  • Telemedicine offers a potential solution for remote patient monitoring and care.

Purpose of the Study:

  • To evaluate the effectiveness of a telemedicine clinic for pediatric patients with poorly controlled type 1 diabetes.
  • To assess changes in glycemic control (HbA1c) after implementing a telemedicine intervention.

Main Methods:

  • Retrospective study of 31 pediatric patients with type 1 diabetes.
  • Utilized a telemedicine model with a group messaging system for communication with a diabetic care team.
  • Insulin dose adjustments were made via electronic communication.

Main Results:

  • Significant reductions in HbA1c levels were observed at 3 months (9.1% vs. 11.1%) and 6.5 months (9.5% vs. 11.1%) compared to baseline.
  • No significant differences in HbA1c were found across age groups, insulin delivery methods, or number of telemedicine encounters.
  • Telemedicine intervention led to improved, but not optimal, diabetes control.

Conclusions:

  • Telemedicine is a viable tool for improving glycemic control in pediatric type 1 diabetes.
  • Further enhancements may be needed to achieve optimal diabetes management through telemedicine.
  • This approach facilitates communication and insulin adjustments for better patient outcomes.

Related Concept Videos

Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Type I Diabetes I: Introduction01:12

Type I Diabetes I: Introduction

Type 1 diabetes mellitus is a chronic metabolic disorder characterized by an absolute deficiency of insulin resulting from the autoimmune destruction of pancreatic β-cells. Although it can occur at any age, it is most commonly diagnosed in childhood, adolescence, or early adulthood. The loss of insulin production impairs cellular glucose uptake, resulting in persistent hyperglycemia and necessitating lifelong insulin therapy.Autoimmune Destruction of β-CellsThe hallmark of type 1 diabetes is an...